Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Artificial Pancreas Device System Market Size From 2025 to 2034?
In recent times, the market for the Artificial Pancreas Device System has seen substantial growth. It’s estimated that the market will expand from $1.81 billion in 2024 to $2.06 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 13.8%. Factors contributing to this growth during the historic period include an increase in investment inflow, escalated government involvement in clinical studies, a heightened demand for automated glycemic control systems, concerted research and development endeavors by industry participants, and a rise in the elderly population.
Expectations are high for a swift expansion in the market size of the artificial pancreas device system in the upcoming years. It’s forecasted to soar to about $3.46 billion in 2029, achieving a 13.8% compound annual growth rate (CAGR). This growth over the projection period can be credited to the expanding incidence of diabetes, heightened cases of pancreatic cancer, growing rates of diabetes coupled with obesity, surge in demand for minimally invasive (MI) drug delivery systems, and advances in diabetes management technology. The period is set to witness key trends such as technological breakthroughs, surge in research and development pursuits, rise in product approvals, cooperation and alliances, as well as an uptick in tele consultations for follow-up.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
What External and Internal Drivers Are Contributing to the Growth of theArtificial Pancreas Device System Market?
The rise in pancreatic cancer cases is anticipated to stimulate the expansion of the artificial pancreas device system market. Pancreatic cancer, primarily a malignant tumor developing in the pancreas, a gland situated behind the stomach, is affected by an array of factors such as lifestyle, genetics, medical conditions, and the environment. In addition, genetic mutations leading to hereditary pancreatitis, resulting in chronic pancreatic inflammation also plays a role. The artificial pancreas device system (APDS) principally aids those suffering from diabetes in controlling their blood sugar by routinely checking glucose levels and dispensing the necessary insulin. For example, Cancer Australia, a government agency, calculated that in 2023 there were 4,506 new instances of pancreatic cancer, showing an increase from the 3,751 cases recorded in the preceding five years as of March 2024. Thus, the escalating prevalence of pancreatic cancer is propelling the growth of the artificial pancreas device system market.
What Segment Types Define the Artificial Pancreas Device System Market Structure?
The artificial pancreas device systemmarket covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
3) By End-User: Hospitals; Medical Centers; Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Artificial Pancreas Device System Market?
Leading firms in the artificial pancreas device system market are working on creating autonomous insulin delivery mechanisms aimed at improving diabetes management. This is done by naturalistically tracking blood sugar levels and dispensing the necessary insulin dosage. The goal of these systems is to mimic the functions of a healthy pancreas, thereby alleviating the strain of regular blood sugar checks and manual insulin delivery for diabetes patients. For instance, in May of 2023, Beta Bionics, an American medical equipment manufacture, obtained FDA 510(k) clearance for their iLet Insulin-Only Bionic Pancreas System, which is an autonomous insulin delivery device. This artificial pancreas system is engineered to independently calculate and administer insulin dosages to manage blood glucose levels. Its closed-loop system continually adjusts insulin dispensation based on the user’s glucose levels, which are gauged by an attached continuous glucose monitor (CGM). All that’s required from the user is their body weight and an estimated meal size for the system to autonomously alter insulin dispensation.
View the full report here:
What Is the Definition of the Artificial Pancreas Device System Market?
Artificial pancreas device system (APDS) is a medical technology designed to automate blood glucose control for individuals with diabetes. The system integrates continuous glucose monitoring (CGM) with an insulin pump, and uses a sophisticated algorithm to automatically adjust insulin delivery based on real-time glucose readings. The device aims to mimic the glucose-regulating function of a healthy pancreas, thereby reducing the need for manual blood glucose monitoring and insulin injections, and helping to maintain blood glucose levels within a target range.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model